Hypermethylated PCDHGB7 as a universal cancer only marker and its application in early cervical cancer screening

Clin Transl Med. 2021 Jun;11(6):e457. doi: 10.1002/ctm2.457.

¹ Research and Development Department, Shanghai Epiprobe Bio-Technology Co., Ltd, Shanghai, China.
² Department of Obstetrics and Gynecology, Jinshan Hospital of Fudan University, Shanghai, China.
³ Shanghai Public Health Clinical Center, Department of General Surgery, Huashan Hospital, Cancer Metastasis Institute, Laboratory of RNA Epigenetics, Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
⁴ Medical Center for Diagnosis and Treatment of Cervical Disease, Obstetrics and Gynecology Hospital, Fudan University, Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases, Shanghai, China.
⁵ Department of Gynecology, International Peace Maternity and Child Health Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

No abstract available

Publication types